Inactive Instrument

Infopia Co.,Ltd Stock Korea S.E.

036220

KR7036220002

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
-	-

08/09/25	Sewon Co.,Ltd and Polaris AI Corp. completed the acquisition of 36.8% stake in HANDYSOFT, Inc. from Osang Healthcare Co.,Ltd, Osang Co., Ltd.,Lee Dong-hyun, Park Cho-ok and Lee Guk-rae.	CI
21/07/25	Sewon Co.,Ltd and Polaris AI Corp. agreed to acquire 36.8% stake in HANDYSOFT, Inc. from Osang Healthcare Co.,Ltd, Osang Co., Ltd.,Lee Dong-hyun, Park Cho-ok and Lee Guk-rae for KRW 50 billion.	CI

Osang HealthCare Co Ltd is a Korea-based company primarily engaged in research and development of in vitro diagnostic medical devices. The Company operates through three segments. The Biochemical Diagnostic segment mainly develops products such as personal blood sugar measurement devices, glycated hemoglobin measurement devices, cholesterol measurement devices, liver disease measurement devices, and U-healthcare devices. The Immunodiagnostic segment is mainly engaged in the development of immunodiagnostic devices and measurement sensors. The Molecular Diagnostic segment mainly engages in the development of molecular diagnostic devices and reagents.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

-40%: Exceptional extension

SEIZE THE OFFER!

Market Cap	87.95B 64.8M 64.8M 56.63M 53.22M 48.57M 91.16M 6.19B 91.17M 639M 246M 3.16B 243M 238M 10.2B	P/E 2024	-13.6x	P/E 2025	52.5x
Enterprise Value	90.43B 66.63M 66.63M 58.23M 54.73M 49.94M 93.73M 6.37B 93.75M 657M 253M 3.25B 250M 245M 10.49B	EV / Sales 2024	1.82x	EV / Sales 2025	1.29x
Free-Float	37.73%	Yield 2024	4.39%	Yield 2025	-

08/09/25	Sewon Co.,Ltd and Polaris AI Corp. completed the acquisition of 36.8% stake in HANDYSOFT, Inc. from Osang Healthcare Co.,Ltd, Osang Co., Ltd.,Lee Dong-hyun, Park Cho-ok and Lee Guk-rae.	CI
21/07/25	Sewon Co.,Ltd and Polaris AI Corp. agreed to acquire 36.8% stake in HANDYSOFT, Inc. from Osang Healthcare Co.,Ltd, Osang Co., Ltd.,Lee Dong-hyun, Park Cho-ok and Lee Guk-rae for KRW 50 billion.	CI
16/12/24	Osang Healthcare Co.,Ltd announces Annual dividend, payable on April 10, 2025	CI
23/09/24	Tranche Update on Osang Healthcare Co.,Ltd's Equity Buyback Plan announced on June 17, 2024.	CI
23/09/24	Tranche Update on Osang Healthcare Co.,Ltd's Equity Buyback Plan announced on June 17, 2024.	CI
17/09/24	Osang Healthcare Co.,Ltd's Equity Buyback announced on June 17, 2024, has expired with 315,680 shares, representing 2.27% for KRW 4,993.67 million.	CI
17/06/24	Osang Healthcare Co.,Ltd announces an Equity Buyback for 375,657 shares.	CI
17/06/24	Osang Healthcare Co.,Ltd authorizes a Buyback Plan.	CI
22/05/24	Allez Health, Inc. announced that it has received $60 million in funding from Osang Healthcare Co.,Ltd	CI
24/04/24	Zense-Life Inc announced that it has received $60 million in funding from Osang Healthcare Co.,Ltd and other investors	CI
28/03/24	Kryptos Biotechnologies, Inc. announced that it has received $10 million in funding from Osang Healthcare Co.,Ltd	CI
18/03/24	Kryptos Biotechnologies, Inc. announced that it expects to receive $27.095308 million in funding from Osang Healthcare Co.,Ltd	CI

Manager	Title	Age	Since
Cheol-Hun Kang CEO	Chief Executive Officer	65	-
Byung-Yeol Yoo CEO	Chief Executive Officer	58	-
Mi-Sook Park COO	Chief Operating Officer	52	-

Director	Title	Age	Since
Byung-Yeol Yoo BRD	Director/Board Member	58	-
Yeo-Min Yoon BRD	Director/Board Member	57	11/08/2020
Jong-Nam Ahn CHM	Chairman	67	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GUARDANT HEALTH, INC.	+1.89%	+0.86%	+196.35%	+583.22%	23.33B
10X GENOMICS, INC.	+2.02%	+8.48%	+518.87%	+95.16%	10.31B
BIOMÉRIEUX	+1.31%	+0.62%	-35.80%	-19.45%	9.76B
CARIS LIFE SCIENCES, INC.	+2.68%	+10.42%	-4.46%	-	8.66B
LANTHEUS HOLDINGS, INC.	-0.28%	-0.72%	+99.56%	+61.76%	6.55B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	+0.86%	+1.06%	-26.84%	-20.16%	5.76B
DIASORIN S.P.A.	-2.31%	+2.70%	-2.56%	-11.97%	4.43B
ANDON HEALTH CO., LTD.	+0.89%	+8.41%	+66.45%	+71.51%	4B
AUTOBIO DIAGNOSTICS CO., LTD.	+7.53%	+10.21%	-12.27%	-25.05%	2.77B
Average	+1.37%	+5.19%	+88.81%	+91.88%	8.4B
Weighted average by Cap.	+1.26%	+4.69%	+135.77%	+221.99%

Infopia Co.,Ltd Stock Korea S.E.

Stocks

036220

KR7036220002

Medical Equipment, Supplies & Distribution

Valuation: Infopia Co.,Ltd

Latest news: Infopia Co.,Ltd

Managers and Directors: Infopia Co.,Ltd

Diagnostic & Testing Substances

Financials

Company Profile

	2024	2025
Net sales	80.49B 59.31M 59.31M 51.83M 48.71M 44.45M 83.43M 5.67B 83.44M 585M 226M 2.9B 223M 218M 9.33B	129B 94.78M 94.78M 82.82M 77.84M 71.04M 133M 9.06B 133M 934M 361M 4.63B 356M 348M 14.92B
Net income	-11.36B -8.37M -8.37M -7.32M -6.88M -6.28M -11.78M -800M -11.78M -82.54M -31.85M -409M -31.45M -30.76M -1.32B	3.11B 2.29M 2.29M 2M 1.88M 1.72M 3.22M 219M 3.22M 22.58M 8.71M 112M 8.6M 8.41M 361M
Net Debt	-9.47B -6.98M -6.98M -6.1M -5.73M -5.23M -9.82M -667M -9.82M -68.79M -26.55M -341M -26.21M -25.63M -1.1B	2.49B 1.83M 1.83M 1.6M 1.51M 1.37M 2.58M 175M 2.58M 18.07M 6.97M 89.5M 6.88M 6.73M 289M